Selective Retina Therapy with Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients
Ye Ji Kim, Youn Gon Lee, Dong Won Lee, Jae Hui Kim, Ye Ji Kim, Youn Gon Lee, Dong Won Lee, Jae Hui Kim
Abstract
Purpose: To evaluate short-term treatment outcomes following selective retina therapy (SRT) with real-time feedback-controlled dosimetry in Korean patients with acute idiopathic central serous chorioretinopathy (CSC).
Methods: Sixteen eyes (16 patients) with acute idiopathic CSC (symptom duration < 3 months) were included in this retrospective study. All patients underwent a single session of SRT with real-time feedback-controlled dosimetry. Best-corrected visual acuity (BCVA) and central foveal thickness (CFT) before and 3 months after treatment were examined and compared.
Results: The logarithm of minimal angle of resolution BCVA was significantly better 3 months after treatment (0.16 ± 0.18) than at the time of diagnosis (0.27 ± 0.18, P = 0.002). Additionally, subretinal fluid had resolved in all 16 eyes 3 months after treatment and CFT was significantly lower 3 months after treatment (215.6 ± 17.9 μm) than at baseline (441.4 ± 124.8 μm, P < 0.001). No notable SRT-related complications were observed during the study period.
Conclusion: The results of the present study suggest that SRT is a useful therapeutic option for patients with acute idiopathic CSC. Further studies are required to better understand the long-term efficacy of this treatment. This trial is registered with clinical trial registration number NCT03339856.
Figures
References
- Gass J. D. Pathogenesis of disciform detachment of the neuroepithelium: II. Idiopathic Central Serous Choroidopathy. American Journal of Ophthalmology. 63(3, Part 2):587–615.
- Hussain D., Gass J. D. Idiopathic central serous chorioretinopathy. Indian Journal of Ophthalmology. 1998;46(3):131–137.
- Gass J. D. Photocoagulation treatment of idiopathic central serous choroidopathy. Transactions Section on Ophthalmology American Academy of Ophthalmology and Otolaryngology. 1977;83, 3 Part 1:456–467.
- Taban M., Boyer D. S., Thomas E. L., Taban M. Chronic central serous chorioretinopathy: photodynamic therapy. American Journal of Ophthalmology. 2004;137(6):1073–1080. doi: 10.1016/j.ajo.2004.01.043.
- Torres-Soriano M. E., Garcia-Aguirre G., Kon-Jara V., et al. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports) Graefe's Archive for Clinical and Experimental Ophthalmology. 2008;246(9):1235–1239. doi: 10.1007/s00417-008-0856-x.
- Roider J., Brinkmann R., Wirbelauer C., Laqua H., Birngruber R. Retinal sparing by selective retinal pigment epithelial photocoagulation. Archives of Ophthalmology. 1999;117(8):1028–1034. doi: 10.1001/archopht.117.8.1028.
- Elsner H., Pörksen E., Klatt C., et al. Selective retina therapy in patients with central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology. 2006;244(12):1638–1645. doi: 10.1007/s00417-006-0368-5.
- Framme C., Walter A., Berger L., et al. Selective retina therapy in acute and chronic-recurrent central serous chorioretinopathy. Ophthalmologica. 2015;234(4):177–188. doi: 10.1159/000439188.
- Klatt C., Saeger M., Oppermann T., et al. Selective retina therapy for acute central serous chorioretinopathy. The British Journal of Ophthalmology. 2010;95(1):83–88. doi: 10.1136/bjo.2009.178327.
- Park Y. G., Kang S., Kim M., Yoo N., Roh Y. J. Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255(7):1375–1383. doi: 10.1007/s00417-017-3672-3.
- Yasui A., Yamamoto M., Hirayama K., et al. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255(2):243–254. doi: 10.1007/s00417-016-3441-8.
- Roider J., Brinkmann R., Wirbelauer C., Laqua H., Birngruber R. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. The British Journal of Ophthalmology. 2000;84(1):40–47. doi: 10.1136/bjo.84.1.40.
- Turkcu F. M., Sahin A., Bez Y., et al. Vision-related quality of life in patients with chronic central serous chorioretinopathy. Seminars in Ophthalmology. 2013;30(4):272–275. doi: 10.3109/08820538.2013.839818.
- Sahin A., Bez Y., Kaya M. C., Türkcü F. M., Sahin M., Yüksel H. Psychological distress and poor quality of life in patients with central serous chorioretinopathy. Seminars in Ophthalmology. 2013;29(2):73–76. doi: 10.3109/08820538.2013.793728.
- Park Y. G., Seifert E., Roh Y. J., Theisen-Kunde D., Kang S., Brinkmann R. Tissue response of selective retina therapy by means of a feedback-controlled energy ramping mode. Clinical & Experimental Ophthalmology. 2014;42(9):846–855. doi: 10.1111/ceo.12342.
- Schuele G., Elsner H., Framme C., Roider J., Birngruber R., Brinkmann R. Optoacoustic real-time dosimetry for selective retina treatment. Journal of Biomedical Optics. 2005;10(6, article 064022) doi: 10.1117/1.2136327.
- Wallow I. H., Tso M. O. Repair after xenon arc photocoagulation. 2. A clinical and light microscopic study of the evolution of retinal lesions in the rhesus monkey. American Journal of Ophthalmology. 1973;75(4):610–626. doi: 10.1016/0002-9394(73)90813-1.
- Odrobina D., Laudanska-Olszewska I., Gozdek P., Maroszyński M., Amon M. Morphologic changes in the foveal photoreceptor layer before and after laser treatment in acute and chronic central serous chorioretinopathy documented in spectral-domain optical coherence tomography. Journal of Ophthalmology. 2013;2013:6.361513
- Daruich A., Matet A., Dirani A., et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Progress in Retinal and Eye Research. 2015;48:82–118. doi: 10.1016/j.preteyeres.2015.05.003.
- Yannuzzi L. A., Slakter J. S., Gross N. E., et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2003;23(3):288–298. doi: 10.1097/00006982-200306000-00002.
- Reibaldi M., Cardascia N., Longo A., et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. American Journal of Ophthalmology. 2010;149(2):307–315.e2. doi: 10.1016/j.ajo.2009.08.026.
- Oiwa K., Kataoka K., Maruko R., Ueno S., Ito Y., Terasaki H. Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms. Japanese Journal of Ophthalmology. 2017;61(3):260–266. doi: 10.1007/s10384-017-0498-9.
- Aydin E. The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy. Journal of Ocular Pharmacology and Therapeutics. 2013;29(1):10–13. doi: 10.1089/jop.2012.0072.
- Shin K. H., Kim J. H., Cho S. W., Lee T. G., Kim C. G., Kim J. W. Efficacy of intravitreal bevacizumab for recurrent central serous chorioretinopathy in patients who had previously responded well to the same therapy. Journal of Ocular Pharmacology and Therapeutics. 2016;32(7):425–430. doi: 10.1089/jop.2015.0149.
- Bae S. H., Heo J., Kim C., et al. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial. Ophthalmology. 2014;121(2):558–565. doi: 10.1016/j.ophtha.2013.09.024.
- Chung Y. R., Seo E. J., Lew H. M., Lee K. H. Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review. Eye (London, England) 2013;27(12):1339–1346. doi: 10.1038/eye.2013.236.
- Lanzetta P., Furlan F., Morgante L., Veritti D., Bandello F. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. European Journal of Ophthalmology. 2008;18(6):934–940.
- Chen S. N., Hwang J. F., Tseng L. F., Lin C. J. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology. 2008;115(12):2229–2234. doi: 10.1016/j.ophtha.2008.08.026.
- Herold T. R., Prause K., Wolf A., Mayer W. J., Ulbig M. W. Spironolactone in the treatment of central serous chorioretinopathy - a case series. Graefe's Archive for Clinical and Experimental Ophthalmology. 2014;252(12):1985–1991. doi: 10.1007/s00417-014-2780-6.
- Bousquet E., Beydoun T., Rothschild P. R., et al. Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study. Retina. 2015;35(12):2505–2515. doi: 10.1097/IAE.0000000000000614.
- Brinkmann R., Roider J., Birngruber R. Selective retina therapy (SRT): a review on methods, techniques, preclinical and first clinical results. Bulletin de la Société Belge d'Ophtalmologie. 2006;(302):51–69.
- Roider J., Hillenkamp F., Flotte T., Birngruber R. Microphotocoagulation: selective effects of repetitive short laser pulses. Proceedings of the National Academy of Sciences of the United States of America. 1993;90(18):8643–8647. doi: 10.1073/pnas.90.18.8643.
- Brinkmann R., Huttmann G., Rogener J., Roider J., Birngruber R., Lin C. P. Origin of retinal pigment epithelium cell damage by pulsed laser irradiance in the nanosecond to microsecond time regimen. Lasers in Surgery and Medicine. 2000;27(5):451–464. doi: 10.1002/1096-9101(2000)27:5<451::AID-LSM1006>;2-1.
- Schuele G., Rumohr M., Huettmann G., Brinkmann R. RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen. Investigative Ophthalmology & Visual Science. 2005;46(2):714–719. doi: 10.1167/iovs.04-0136.
- Kitzmann A. S., Pulido J. S., Diehl N. N., Hodge D. O., Burke J. P. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology. 2008;115(1):169–173. doi: 10.1016/j.ophtha.2007.02.032.
- Tsai D. C., Chen S. J., Huang C. C., et al. Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study. PLoS One. 2013;8(6, article e66858) doi: 10.1371/journal.pone.0066858.
- Fujimoto H., Gomi F., Wakabayashi T., Sawa M., Tsujikawa M., Tano Y. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. Ophthalmology. 2008;115(9):1494–1500.e2. doi: 10.1016/j.ophtha.2008.01.021.
- Gupta V., Gupta P., Dogra M. R., Gupta A. Spontaneous closure of retinal pigment epithelium microrip in the natural course of central serous chorioretinopathy. Eye. 2010;24(4):595–599. doi: 10.1038/eye.2009.193.
- Roberts P., Baumann B., Lammer J., et al. Retinal pigment epithelial features in central serous chorioretinopathy identified by polarization-sensitive optical coherence tomography. Investigative Ophthalmology & Visual Science. 2016;57(4):1595–1603. doi: 10.1167/iovs.15-18494.
- Wood E. H., Karth P. A., Sanislo S. R., Moshfeghi D. M., Palanker D. V. Nondamaging retinal laser therapy for treatment of central serous chorioretinopathy: what is the evidence? Retina. 2017;37(6):1021–1033. doi: 10.1097/IAE.0000000000001386.
Source: PubMed